CS410491A3 - Heterocyclic derivatives, process of their preparation and pharmaceutical containing them - Google Patents

Heterocyclic derivatives, process of their preparation and pharmaceutical containing them

Info

Publication number
CS410491A3
CS410491A3 CS914104A CS410491A CS410491A3 CS 410491 A3 CS410491 A3 CS 410491A3 CS 914104 A CS914104 A CS 914104A CS 410491 A CS410491 A CS 410491A CS 410491 A3 CS410491 A3 CS 410491A3
Authority
CS
Czechoslovakia
Prior art keywords
preparation
heterocyclic derivatives
pharmaceutical containing
pharmaceutical
heterocyclic
Prior art date
Application number
CS914104A
Other languages
English (en)
Inventor
Gerhard Dr Walther
Claus S Dr Scheider
Heinz Karl Dr Weber
Armin Dr Fugner
Original Assignee
Boehringer Sohn Ingelheim
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Sohn Ingelheim filed Critical Boehringer Sohn Ingelheim
Publication of CS410491A3 publication Critical patent/CS410491A3/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/18—Dibenzazepines; Hydrogenated dibenzazepines
    • C07D223/20—Dibenz [b, e] azepines; Hydrogenated dibenz [b, e] azepines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D267/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D267/02—Seven-membered rings
    • C07D267/08—Seven-membered rings having the hetero atoms in positions 1 and 4
    • C07D267/12—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D267/16—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems condensed with two six-membered rings
    • C07D267/20—[b, f]-condensed
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D281/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D281/02—Seven-membered rings
    • C07D281/04—Seven-membered rings having the hetero atoms in positions 1 and 4
    • C07D281/08—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D281/12—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems condensed with two six-membered rings
    • C07D281/16—[b, f]-condensed
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
CS914104A 1980-03-08 1991-12-27 Heterocyclic derivatives, process of their preparation and pharmaceutical containing them CS410491A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19803008944 DE3008944A1 (de) 1980-03-08 1980-03-08 Dibenzimidazoazepine, ihre herstellung und verwendung

Publications (1)

Publication Number Publication Date
CS410491A3 true CS410491A3 (en) 1992-05-13

Family

ID=6096617

Family Applications (2)

Application Number Title Priority Date Filing Date
CS811644A CS221288B2 (en) 1980-03-08 1981-03-06 Method of making the heterocyclic compounds
CS914104A CS410491A3 (en) 1980-03-08 1991-12-27 Heterocyclic derivatives, process of their preparation and pharmaceutical containing them

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CS811644A CS221288B2 (en) 1980-03-08 1981-03-06 Method of making the heterocyclic compounds

Country Status (29)

Country Link
US (1) US4313931A (cs)
EP (1) EP0035749B1 (cs)
JP (1) JPS56139484A (cs)
AU (1) AU535359B2 (cs)
BG (1) BG33886A3 (cs)
CA (1) CA1150253A (cs)
CS (2) CS221288B2 (cs)
DD (1) DD156708A5 (cs)
DE (2) DE3008944A1 (cs)
DK (1) DK154299C (cs)
ES (1) ES8301481A1 (cs)
FI (1) FI70898C (cs)
GB (1) GB2071095B (cs)
GR (1) GR74805B (cs)
HK (1) HK63186A (cs)
HU (1) HU180628B (cs)
IE (1) IE51015B1 (cs)
IL (1) IL62309A (cs)
MX (1) MX6869E (cs)
NO (1) NO162073C (cs)
NZ (1) NZ196446A (cs)
PH (1) PH15839A (cs)
PL (1) PL132141B1 (cs)
PT (1) PT72631B (cs)
RO (1) RO81652B (cs)
SU (1) SU1015829A3 (cs)
UA (1) UA8041A1 (cs)
YU (1) YU42557B (cs)
ZA (1) ZA811500B (cs)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3134672A1 (de) * 1981-09-02 1983-03-17 Boehringer Ingelheim KG, 6507 Ingelheim Heterocyclische verbindungen, ihre herstellung und verwendung
EP0130202A1 (en) * 1982-12-30 1985-01-09 Beecham Group Plc Tetracyclic compounds
DE4102148A1 (de) * 1991-01-25 1992-07-30 Boehringer Ingelheim Kg Verfahren zur herstellung von 3-amino-9,13b-dihydro-1h-dibenz-(c,f)imidazol(1,5-a)azepin-hydrochlorid
DE19542281C2 (de) * 1995-11-14 1997-12-04 Boehringer Ingelheim Kg Verwendung von Epinastin für die Behandlung der Migräne
DE19954516A1 (de) * 1999-11-12 2001-05-17 Boehringer Ingelheim Int Epinastin-haltige Lösungen
DE19958460A1 (de) * 1999-12-03 2001-06-07 Boehringer Ingelheim Pharma Verfahren zur Herstellung von Epinastine-Hydrochlorid in der hochschmelzenden Kristallmodifikation
US7776315B2 (en) * 2000-10-31 2010-08-17 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmaceutical compositions based on anticholinergics and additional active ingredients
US20100310477A1 (en) * 2000-11-28 2010-12-09 Boehringer Ingelheim Pharma Gmbh & Co. Kg. Pharmaceutical compositions based on anticholingerics and additional active ingredients
DE10152973A1 (de) * 2001-10-26 2003-05-08 Boehringer Ingelheim Int Neue trockene und wässrige Epinastin-Sirup-Formulierung
JP4298212B2 (ja) * 2002-03-29 2009-07-15 大日本印刷株式会社 塩酸エピナスチン高融点型結晶の製造法
DK1496051T3 (da) * 2002-04-11 2007-03-26 Konica Minolta Chemical Co Ltd Fremgangsmåde til fremstilling af 6-aminomethyl-6,11-dihydro-5H-dibenz[b,e]azepin
JP4514017B2 (ja) * 2003-03-27 2010-07-28 大日本印刷株式会社 塩酸エピナスチンの製造方法
US8758816B2 (en) * 2004-11-24 2014-06-24 Meda Pharmaceuticals Inc. Compositions comprising azelastine and methods of use thereof
US20070020330A1 (en) * 2004-11-24 2007-01-25 Medpointe Healthcare Inc. Compositions comprising azelastine and methods of use thereof
ES2704482T3 (es) 2004-11-24 2019-03-18 Meda Pharmaceuticals Inc Composiciones que comprenden azelastina y sus métodos de uso
US20090143359A1 (en) * 2005-07-08 2009-06-04 Akiharu Isowaki Percutaneously Absorptive Ophthalmic Preparation Comprising Epinastine
US7247623B2 (en) * 2005-08-19 2007-07-24 Inspire Pharmaceuticals, Inc. Method of treating dry eye disease with non-drying antihistamines
KR101386530B1 (ko) 2006-12-29 2014-04-18 케이피엑스 라이프사이언스 주식회사 순도 및 수율이 향상된3-아미노-9,13ｂ디하이드로-1Ｈ-디벤즈-[ｃ,ｆ]이미다조[1,5-ａ]-아제핀 염산염의 제조방법
WO2009063504A2 (en) * 2007-09-24 2009-05-22 Usv Limited Novel crystal modification of epinastine or salts thereof and process for preparation thereof
WO2010021681A2 (en) * 2008-08-18 2010-02-25 Combinatorx (Singapore) Pte. Ltd. Compositions and methods for treatment of viral diseases
JP2010120960A (ja) * 2010-02-17 2010-06-03 Dainippon Printing Co Ltd 塩酸エピナスチンの製造方法
JP6006634B2 (ja) * 2011-12-28 2016-10-12 東和薬品株式会社 イソウレア化合物を用いるエピナスチンの製造方法
CN103172638B (zh) * 2013-03-13 2015-09-16 北京朗依制药有限公司 一种盐酸依匹斯汀的制备方法
CN104098575B (zh) * 2013-04-15 2016-06-01 四川科瑞德凯华制药有限公司 一种盐酸依匹斯汀晶型及其制备方法和用途
KR102041389B1 (ko) 2017-12-12 2019-11-27 (주)프론트바이오 N-(9,13b-디하이드로-1H-디벤조[c,f]이미다조[1,5-a]아제핀-3-일)-2-하이드록시벤즈아미드 및 2-((9,13b-디하이드로-1H-디벤조[c,f]이미다조[1,5-a]아제핀-3-일) 카바모일)페닐 아세테이트의 화합물, 이의 제조방법 및 이를 포함하는 항염증 및 진통제 조성물
KR102080239B1 (ko) 2019-08-06 2020-02-21 한양대학교 에리카산학협력단 에피나스틴의 신규 제조방법

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE789410A (fr) * 1971-10-05 1973-01-15 Akzo Nv Nieuwe imidazolidine derivaten
NL7202963A (cs) * 1972-03-07 1973-09-11
NL7414038A (nl) * 1974-10-28 1976-05-03 Akzo Nv Nieuwe tetracyclische pyrrolidino derivaten.

Also Published As

Publication number Publication date
DD156708A5 (de) 1982-09-15
YU56881A (en) 1983-10-31
JPS56139484A (en) 1981-10-30
GB2071095B (en) 1983-06-02
FI810712L (fi) 1981-09-09
DK154299B (da) 1988-10-31
PL132141B1 (en) 1985-02-28
RO81652A (ro) 1983-04-29
US4313931A (en) 1982-02-02
DK154299C (da) 1989-03-28
CS221288B2 (en) 1983-04-29
NO162073C (no) 1989-11-01
YU42557B (en) 1988-10-31
AU6815881A (en) 1981-09-17
PH15839A (en) 1983-04-08
AU535359B2 (en) 1984-03-15
ZA811500B (en) 1982-11-24
IL62309A (en) 1984-06-29
ES500150A0 (es) 1982-12-01
BG33886A3 (en) 1983-05-16
EP0035749B1 (de) 1984-06-06
IL62309A0 (en) 1981-05-20
PT72631B (fr) 1982-12-30
DE3008944A1 (de) 1981-09-24
RO81652B (ro) 1983-04-30
UA8041A1 (uk) 1995-12-26
EP0035749A1 (de) 1981-09-16
FI70898B (fi) 1986-07-18
DK103581A (da) 1981-09-09
NO162073B (no) 1989-07-24
FI70898C (fi) 1986-10-27
PL230036A1 (cs) 1982-05-24
SU1015829A3 (ru) 1983-04-30
HU180628B (en) 1983-03-28
NZ196446A (en) 1984-07-06
MX6869E (es) 1986-09-11
JPH0366311B2 (cs) 1991-10-16
PT72631A (fr) 1981-04-01
GR74805B (cs) 1984-07-12
IE51015B1 (en) 1986-09-03
GB2071095A (en) 1981-09-16
DE3163938D1 (en) 1984-07-12
CA1150253A (en) 1983-07-19
HK63186A (en) 1986-09-05
IE810485L (en) 1981-09-08
NO810762L (no) 1981-09-09
ES8301481A1 (es) 1982-12-01

Similar Documents

Publication Publication Date Title
CS410491A3 (en) Heterocyclic derivatives, process of their preparation and pharmaceutical containing them
DE2960553D1 (en) Derivatives of carbazolyl-4-oxypropanolamine, methods for their preparation and medicines containing them
DE2960222D1 (en) Phenoxyalkylcarboxylic-acid derivatives, process for their preparation and medicaments containing them
IL64573A (en) Derivatives of formylphenoxyalkanoic acids and formylphenoxymethylbenzoic acids,their preparation and pharmaceutical formulations containing them
IL64315A (en) 1-sulfo-oxoazetidine derivatives,their production and pharmaceutical compositions containing them
PH15719A (en) Aminoalkylbenzoic derivatives,pharmaceutical composition and method of use
EP0049173A3 (en) Pyrimidone derivatives, processes for their preparation and pharmaceutical derivatives containing them
EP0094271A3 (en) Aryl and heteroaryl carboxamide derivatives, process for their preparation and medicaments containing them
DE3161611D1 (en) Novel pyridinecarboxamide derivatives, a process for the preparation thereof, the use of said derivatives and a pharmaceutical composition containing same
GB2095668B (en) Acylquinolinone derivatives process for their manufacture pharmaceutical preparations containing them and their use
DE3161238D1 (en) 20-deoxyrosaramicin derivatives, process for their preparation and pharmaceutical compositions containing them
PT73061B (en) Process for the preparation of new derivatives of taurina and its pharmaceutical use
DE2961983D1 (en) Pyrrolidine-2-methanol derivatives, process for their preparation and medicaments containing them
DE3166656D1 (en) 1-phenyl-2-cyclohexene-1-alkylamine derivatives, process for their preparation and medicines containing them
IL62229A0 (en) Heterocyclic derivatives,their preparation and pharmaceutical compositions containing them
DE3173643D1 (en) Cephalosporin derivatives, process for their preparation, pharmaceutical compositions containing them and intermediates for their preparation
DE3167672D1 (en) Substituted phenoxy-aminopropanol derivatives, intermediates and process for their preparation and medicament containing them
DE2964198D1 (en) Indanamine derivatives, process for their preparation and medicaments containing them
JPS5777679A (en) Novel heterocyclic derivative, manufacture and pharmaceutical composition containing same
IL64123A (en) Biphenylyloxypropoxypyrimidine derivatives,process for their preparation and pharmaceutical compositions containing them
GB2064515B (en) Heterocyclic derivatives processes for their production and pharmaceutical compositions containing them
CY1339A (en) Process for the manufacture of novel benzazole derivatives,pharmaceutical preparations containing these derivatives and their use
DE3162256D1 (en) Substituted phenoxy-aminopropanol derivatives, intermediates and processes for their production, and pharmaceutical preparations containing them
PH17057A (en) Kijanimicin and salts thereof,pharmaceutical compositions containing same and process of preparring same
PH16128A (en) Benzodiazepine derivatives,their pharmaceutical composition and method of use